TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 96nMAssay Description:Competitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 310nMAssay Description:Uncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 320nMAssay Description:Mixed inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 480nMAssay Description:Noncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 2.51nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2.63nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 2.63nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 2.82nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 4.90nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 5.62nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 6.46nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 6.61nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 8.13nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 11.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 14.8nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 17.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 19.1nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 22.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 22.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 27.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 30.2nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 30.9nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 32.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 34.7nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 45.7nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 55.0nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 70.8nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 70.8nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 81.3nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 81.3nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 83.2nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 87.1nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 95.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 107nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 115nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 129nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 141nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 141nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 209nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 219nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 229nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 363nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 447nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 525nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 603nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair